Boniva vs. Prolia

See how Boniva and Prolia compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Boniva is a once-monthly oral tablet, while Prolia is an injection given by a healthcare provider once every 6 months.

  • Boniva is approved only for postmenopausal women, while Prolia covers postmenopausal women, men, and people with steroid- or cancer-treatment-related bone loss.

  • Both drugs carry warnings for osteonecrosis of the jaw and atypical femoral fractures, but Prolia also carries a boxed warning for severe hypocalcemia in advanced kidney disease.

Boniva vs. Prolia Drug Summary

Boniva

Boniva (ibandronate) is a nitrogen-containing bisphosphonate used to treat and prevent osteoporosis in postmenopausal women. It comes as a tablet taken once a month on an empty stomach, and the person must stay upright for 60 minutes afterward to avoid esophageal irritation.

Prolia

Prolia (denosumab) is a RANK ligand inhibitor given as an injection every 6 months in a doctor's office or clinic. It treats osteoporosis in postmenopausal women, men, and people at high fracture risk from steroid use, prostate cancer therapy, or breast cancer therapy.

Boniva vs. Prolia Side Effects

Boniva

Most common
pain in extremity (>5%)
back pain (>5%)
dyspepsia (>5%)
diarrhea (>5%)

Prolia

Most common
pain in extremity (up to 11.4%)
back pain (up to 34.1%)
musculoskeletal pain (up to 7.4%)
hypercholesterolemia (up to 7.2%)

Boniva vs. Prolia Dosage

Boniva

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 150 mg once monthly At the start
Maximum dose 150 mg once monthly Same as starting
Dose changes None Fixed dose

Prolia

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 60 mg once every 6 months At the start
Maximum dose 60 mg once every 6 months Same as starting
Dose changes None Fixed dose

Boniva vs. Prolia Indications

Boniva

Boniva is FDA-approved to treat and prevent osteoporosis in postmenopausal women. It is not approved for men or for pediatric patients.

  • Treatment of osteoporosis in postmenopausal women

  • Prevention of osteoporosis in postmenopausal women

  • Not approved for men with osteoporosis

  • Not approved for pediatric use

Prolia

Prolia is approved for a wider range of patients, including postmenopausal women, men, and people whose bone loss is linked to certain cancer treatments or steroid use. It is used specifically in patients considered at high risk for fracture.

  • Postmenopausal women at high fracture risk

  • Men with osteoporosis at high fracture risk

  • Glucocorticoid-induced osteoporosis in men and women

  • Men on androgen deprivation therapy for prostate cancer

Boniva vs. Prolia Pros and Cons

Boniva

Boniva offers a simple, self-administered pill taken once a month, but it requires a strict routine around timing and posture to avoid esophageal irritation. Its FDA approval is limited to postmenopausal women, so it is not an option for men or for steroid-related bone loss.

Pros

  • Self-administered tablet, no clinic visit needed

  • Long track record, FDA-approved since 2003

  • Approved for prevention before major bone loss occurs

  • Lower monthly list price ($155 to $285)

Cons

  • Must be taken on an empty stomach and upright for 60 minutes

  • Not approved for men or glucocorticoid-induced osteoporosis

  • Only covers postmenopausal women

  • Common GI side effects like dyspepsia and diarrhea

Prolia

Prolia covers a much broader group of patients, including men and people with cancer-treatment-related bone loss, and only needs to be given twice a year. It requires in-office administration and carries a boxed warning for severe hypocalcemia in patients with advanced kidney disease.

Pros

  • Only 2 doses per year instead of a monthly pill

  • Approved for men and multiple bone-loss conditions

  • No dosing-related esophageal or posture restrictions

  • Given by a healthcare professional, reducing dosing errors

Cons

  • Requires an in-office visit every 6 months

  • Boxed warning for severe hypocalcemia in advanced kidney disease

  • Risk of rebound vertebral fractures if stopped without follow-up therapy

  • Higher list price of $1,600 to $2,000 per injection

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.